Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CAAIF/CIHR-III/CIHR-ICRH Food Allergy Research Grant

University of Calgary

$100,000.00

The early-life mycobiome as a determinant of oral tolerance to food allergens

EF 2023-24

Résumé
Lay Abstract: Our gut plays a crucial role in shaping our immune system, especially during early life. Research has shown that changes in our gut microbiome during this critical period can have lasting effects on our immune development and increase the risk of allergies, including food allergies. However, much of the focus has been on bacteria, leaving the role of fungi in our gut largely unexplored. Fungi are common members of the microbial community in our gut, and they have unique interactions with our immune system that can influence the development of allergies. Similar to bacteria, fungi in the gut are affected by factors such as antibiotic use during infancy and the birth by Caesarean section. These factors are known to impact the microbiome and are associated with an increased risk of food allergies. We and others have identified specific changes in the gut fungal microbiome (called the mycobiome) that are linked to the risk of pediatric allergic asthma. Additionally, we have investigated the effects of infant antibiotic use, a strong risk factor for pediatric allergies, on the gut mycobiome. We found that a particular type of fungus called Malassezia restricta thrives during antibiotic use, leading to a temporary increase in the ratio of fungi to bacteria in the gut. To understand the causal relationship between these fungal changes and the development of allergies, we are using specialized mice that lack any gut microbes and then introduced defined microbial communities. These "gnotobiotic mice" allow us to study how specific microbes, including fungi, affect the immune system. We hypothesize that the blooming of Malassezia restricta due to antibiotic use contributes to immune dysregulation that impairs the induction of oral tolerance to food allergens. Preliminary data from the gnotobiotic mice experiments strongly support this idea. The presence of gut fungi, along with bacteria, seems to have a combined effect on immune development. Furthermore, the presence of this fungus increases susceptibility to allergic immune responses in the gut of these mice. This suggests that the expansion of Malassezia restricta due to infant antibiotic use directly contributes to immune dysregulation, leading to allergic immune responses in the intestine. To further investigate whether these mechanisms impact immune tolerance to food allergens, we propose two research objectives. First, we aim to determine how colonization with or antibiotic induced blooms of Malassezia restricta impact oral tolerance to allergens and the integrity of the intestinal barrier in mice. Second, we plan to study how this fungal species affect the immune response and severity of anaphylaxis to peanut proteins in mice. This research addresses a significant gap in our understanding of how an understudied component of the human gut microbiome contributes to the development of food allergies. By combining expertise in human studies and mouse models, our team aims to uncover the mechanisms behind these allergic responses, ultimately providing valuable insights for potential allergy prevention and management strategies.
Programme
CAAIF/CIHR-III/CIHR-ICRH Food Allergy Research Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
498187
Name
Arrieta Mendez Marie-Claire
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases
Projecttitle
The early-life mycobiome as a determinant of oral tolerance to food allergens
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
CAAIF/CIHR-III/CIHR-ICRH Food Allergy Research Grant
Keyworddelim
Food Allergy; Microbiome; Mycobiome; Oral Tolerance; Peanut Allergy
Abstract
Lay Abstract: Our gut plays a crucial role in shaping our immune system, especially during early life. Research has shown that changes in our gut microbiome during this critical period can have lasting effects on our immune development and increase the risk of allergies, including food allergies. However, much of the focus has been on bacteria, leaving the role of fungi in our gut largely unexplored. Fungi are common members of the microbial community in our gut, and they have unique interactions with our immune system that can influence the development of allergies. Similar to bacteria, fungi in the gut are affected by factors such as antibiotic use during infancy and the birth by Caesarean section. These factors are known to impact the microbiome and are associated with an increased risk of food allergies. We and others have identified specific changes in the gut fungal microbiome (called the mycobiome) that are linked to the risk of pediatric allergic asthma. Additionally, we have investigated the effects of infant antibiotic use, a strong risk factor for pediatric allergies, on the gut mycobiome. We found that a particular type of fungus called Malassezia restricta thrives during antibiotic use, leading to a temporary increase in the ratio of fungi to bacteria in the gut. To understand the causal relationship between these fungal changes and the development of allergies, we are using specialized mice that lack any gut microbes and then introduced defined microbial communities. These "gnotobiotic mice" allow us to study how specific microbes, including fungi, affect the immune system. We hypothesize that the blooming of Malassezia restricta due to antibiotic use contributes to immune dysregulation that impairs the induction of oral tolerance to food allergens. Preliminary data from the gnotobiotic mice experiments strongly support this idea. The presence of gut fungi, along with bacteria, seems to have a combined effect on immune development. Furthermore, the presence of this fungus increases susceptibility to allergic immune responses in the gut of these mice. This suggests that the expansion of Malassezia restricta due to infant antibiotic use directly contributes to immune dysregulation, leading to allergic immune responses in the intestine. To further investigate whether these mechanisms impact immune tolerance to food allergens, we propose two research objectives. First, we aim to determine how colonization with or antibiotic induced blooms of Malassezia restricta impact oral tolerance to allergens and the integrity of the intestinal barrier in mice. Second, we plan to study how this fungal species affect the immune response and severity of anaphylaxis to peanut proteins in mice. This research addresses a significant gap in our understanding of how an understudied component of the human gut microbiome contributes to the development of food allergies. By combining expertise in human studies and mouse models, our team aims to uncover the mechanisms behind these allergic responses, ultimately providing valuable insights for potential allergy prevention and management strategies.
Competitiondate
202309
Approvedterm2
1 yr 0 mth
Pinamesdelim
Arrieta Mendez, Marie-Claire
Approvedterm
1 an 0 mois
Cihrcontribution2
ICRH~ $100,000~ $0~